BPG is committed to discovery and dissemination of knowledge
Featured Articles
1/20/2017 8:47:00 AM | Browse: 902 | Download: 1627
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 29318
Country United States
ISSN 1948-5204 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Editorial
Article Title Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma
Manuscript Source Invited Manuscript
All Author List Tripti Khare, Sharad Khare and Jamal A Ibdah
Funding Agency and Grant Number
Corresponding Author Jamal A Ibdah, MD, PhD, Professor, Director, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Missouri-Columbia, 1 University Blvd, Columbia, MO 65212, United States. ibdahj@health.missouri.edu
Key Words Proteomics; Cancer; Biomarker; Hepato­cellular carcinoma
Core Tip Despite ongoing development in treatment for hepatocellular carcinoma (HCC), effective biomarkers for diagnosis and treatment for HCC are not available. Profiling of proteins puts proteomics on the forefront to understand promising new biomarkers and drug targets for HCC. HCC proteome database would be an important step towards identifying tumor associated proteins as potential therapeutic targets in the treatment of HCC.
Publish Date 2017-01-12 12:07
Citation Khare T, Khare S, Ibdah JA. Proteomics approaches for early detection and targeted therapy of hepatocellular carcinoma. World J Gastrointest Oncol 2017; 9(1): 1-3
URL http://www.wjgnet.com/1948-5204/full/v9/i1/1.htm
DOI http://dx.doi.org/10.4251/wjgo.v9.i1.1
Full Article (PDF) WJGO-9-1.pdf
Full Article (Word) WJGO-9-1.doc